Secondary fibrosarcoma of the brain stem treated with cyclophosphamide and Imatinib

Radiation-induced midbrain fibrosarcoma is a rare, highly aggressive tumor, which is associated with poor prognosis. We present the case of a 48-year old man with brainstem fibrosarcoma 20 years following radiation therapy received for a pituitary tumor. We discuss this case in the context of the di...

Descripción completa

Detalles Bibliográficos
Autores principales: Alexandru, Daniela, Van Horn, Denise K., Bota, Daniela Annenelie
Formato: Texto
Lenguaje:English
Publicado: Springer US 2009
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895888/
https://www.ncbi.nlm.nih.gov/pubmed/20043189
http://dx.doi.org/10.1007/s11060-009-0096-x
_version_ 1782183298802384896
author Alexandru, Daniela
Van Horn, Denise K.
Bota, Daniela Annenelie
author_facet Alexandru, Daniela
Van Horn, Denise K.
Bota, Daniela Annenelie
author_sort Alexandru, Daniela
collection PubMed
description Radiation-induced midbrain fibrosarcoma is a rare, highly aggressive tumor, which is associated with poor prognosis. We present the case of a 48-year old man with brainstem fibrosarcoma 20 years following radiation therapy received for a pituitary tumor. We discuss this case in the context of the diagnostic criteria for these tumors, and previous reports of secondary and primary sarcomas of the central nervous system.
format Text
id pubmed-2895888
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-28958882010-07-29 Secondary fibrosarcoma of the brain stem treated with cyclophosphamide and Imatinib Alexandru, Daniela Van Horn, Denise K. Bota, Daniela Annenelie J Neurooncol Case Report Radiation-induced midbrain fibrosarcoma is a rare, highly aggressive tumor, which is associated with poor prognosis. We present the case of a 48-year old man with brainstem fibrosarcoma 20 years following radiation therapy received for a pituitary tumor. We discuss this case in the context of the diagnostic criteria for these tumors, and previous reports of secondary and primary sarcomas of the central nervous system. Springer US 2009-12-31 2010 /pmc/articles/PMC2895888/ /pubmed/20043189 http://dx.doi.org/10.1007/s11060-009-0096-x Text en © The Author(s) 2009 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
spellingShingle Case Report
Alexandru, Daniela
Van Horn, Denise K.
Bota, Daniela Annenelie
Secondary fibrosarcoma of the brain stem treated with cyclophosphamide and Imatinib
title Secondary fibrosarcoma of the brain stem treated with cyclophosphamide and Imatinib
title_full Secondary fibrosarcoma of the brain stem treated with cyclophosphamide and Imatinib
title_fullStr Secondary fibrosarcoma of the brain stem treated with cyclophosphamide and Imatinib
title_full_unstemmed Secondary fibrosarcoma of the brain stem treated with cyclophosphamide and Imatinib
title_short Secondary fibrosarcoma of the brain stem treated with cyclophosphamide and Imatinib
title_sort secondary fibrosarcoma of the brain stem treated with cyclophosphamide and imatinib
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895888/
https://www.ncbi.nlm.nih.gov/pubmed/20043189
http://dx.doi.org/10.1007/s11060-009-0096-x
work_keys_str_mv AT alexandrudaniela secondaryfibrosarcomaofthebrainstemtreatedwithcyclophosphamideandimatinib
AT vanhorndenisek secondaryfibrosarcomaofthebrainstemtreatedwithcyclophosphamideandimatinib
AT botadanielaannenelie secondaryfibrosarcomaofthebrainstemtreatedwithcyclophosphamideandimatinib

Ejemplares similares